STONY BROOK, NY / ACCESS Newswire / March 26, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that Applied DNA Clinical...
STONY BROOK, NY / ACCESS Newswire / March 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect...
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot
- Announces Exit of DNA Tagging and Security Products and Services Business Segment -
Investor Call and Webcast Scheduled for 4:30 P.M ET
STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to its...
- Signals Start of New Commercialization Phase for LineaRx Subsidiary -
STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced...
- Regulatory Approval Showcases Clinical Advancement of Linea DNAâ„¢ as a Rapid and Effective Means of Producing CAR-T cell Therapies -
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot